Drug-Induced Thrombocytopenia: Is it a Serious Concern for Glycoprotein IIb/IIIa Receptor Inhibitors?
- 1 January 1998
- journal article
- Published by Springer Nature in Journal of Thrombosis and Thrombolysis
- Vol. 5 (3) , 191-202
- https://doi.org/10.1023/A:1008887708104
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Abciximab-associated profound thrombocytopenia: Therapy with immunoglobulin and platelet transfusionThe American Journal of Cardiology, 1996
- Randomized, double-blind, placebo-controlled dose-ranging study of tirofiban (MK-383) platelet IIb/IIIa blockade in high risk patients undergoing coronary angioplastyJournal of the American College of Cardiology, 1996
- Effects of profound platelet inhibition with c7E3 before coronary angioplasty on complications of coronary bypass surgeryThe American Journal of Cardiology, 1994
- Fatal effect of re-exposure to heparin after previous heparin-associated thrombocytopenia and thrombosisThe Lancet, 1990
- Heparin-induced thrombocytopeniaBlood Reviews, 1988
- White Clot Syndrome*Southern Medical Journal, 1988
- Thrombocytopenic Reaction to Aspirin and AcetaminophenNew England Journal of Medicine, 1979
- Aspirin-induced thrombocytopenia on an immune basisThe Lancet Healthy Longevity, 1974
- Haematological Side-effects of some Anti-Rheumatic DrugsAnnals of the Rheumatic Diseases, 1963
- IMMUNOREACTIONS INVOLVING PLATELETSThe Journal of Experimental Medicine, 1958